Condition: Hypertension · Hypertension, Systolic · Hypertension, Essential · Sponsor: Orchestra BioMed, Inc
A prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker.
This description comes directly from the study's public registry record.
Hans-Peter Stoll, MD, PhD · 646-956-2161 · hpstoll@orchestrabiomed.com
Angela Stagg · astagg@orchestrabiomed.com
Always discuss trial participation with your own doctor first.
| HonorHealth | Scottsdale, Arizona, United States | Recruiting |
| Adventist Health Glendale | Glendale, California, United States | Recruiting |
| Hoag Memorial Hospital Presbyterian | Newport Beach, California, United States | Recruiting |
| Stanford | Redwood City, California, United States | Recruiting |
| Scripps Clinic | San Diego, California, United States | Recruiting |
| Sutter Valley Hospitals | San Francisco, California, United States | Recruiting |
| South Denver Cardiology | Denver, Colorado, United States | Recruiting |
| Colorado Heart and Vascular | Golden, Colorado, United States | Recruiting |
| Intermountain Health Lutheran Hospital | Golden, Colorado, United States | Recruiting |
| UCHealth Medical Center of the Rockies | Loveland, Colorado, United States | Recruiting |
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | Recruiting |
| HCA Florida JFK Hospital | Atlantis, Florida, United States | Recruiting |
+ 119 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06059638